![Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO](https://www.gao.gov/assets/extracts/b1ea33f945c9bdf9de3fd32fc2df69d8/rId13_image4.png)
Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO
![FDA Approval of Vaccines and EUA Infographic | Vanderbilt Institute for Infection, Immunology and Inflammation FDA Approval of Vaccines and EUA Infographic | Vanderbilt Institute for Infection, Immunology and Inflammation](https://www.vumc.org/viiii/sites/default/files/public_files/Images/FDA%20%20EUA%20Infographic_TwitterWeb.png)
FDA Approval of Vaccines and EUA Infographic | Vanderbilt Institute for Infection, Immunology and Inflammation
![Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/09/9-3-19-Persepectives-blog-What-is-Phase-1-2-3-image-for-9-3-19-final-.jpg)